376 related articles for article (PubMed ID: 24164845)
1. Methotrexate in ocular manifestations of Behcet's disease: a longitudinal study up to 15 years.
Davatchi F; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Sadeghi Abdollahi B; Faezi T; Akhlaghi M; Ashofteh F
Int J Rheum Dis; 2013 Oct; 16(5):568-77. PubMed ID: 24164845
[TBL] [Abstract][Full Text] [Related]
2. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years.
Davatchi F; Sadeghi Abdollahi B; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Faezi T; Akhlaghi M; Ghodsi Z; Ashofteh F; Mohtasham N
Int J Rheum Dis; 2014 May; 17(4):444-52. PubMed ID: 24314325
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study.
Mohammadi M; Shahram F; Shams H; Akhlaghi M; Ashofteh F; Davatchi F
Int J Rheum Dis; 2017 Sep; 20(9):1269-1276. PubMed ID: 28524639
[TBL] [Abstract][Full Text] [Related]
4. Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).
Davatchi F; Shams H; Rezaipoor M; Sadeghi-Abdollahi B; Shahram F; Nadji A; Chams-Davatchi C; Akhlaghi M; Faezi T; Naderi N
Int J Rheum Dis; 2010 Aug; 13(3):246-52. PubMed ID: 20704622
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cell therapy unable to rescue the vision from advanced Behcet's disease retinal vasculitis: report of three patients.
Davatchi F; Nikbin B; Shams H; Sadeghi Abdollahi B; Mohyeddin M; Shahram F
Int J Rheum Dis; 2013 Apr; 16(2):139-47. PubMed ID: 23773637
[TBL] [Abstract][Full Text] [Related]
6. Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report.
Shahram F; Davatchi F; Chams H; Nadji A; Jamshidi A; Akbarian M; Gharibdoost F
Adv Exp Med Biol; 2003; 528():571-3. PubMed ID: 12918767
[No Abstract] [Full Text] [Related]
7. High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.
Davatchi F; Shahram F; Chams H; Jamshidi AR; Nadji A; Chams C; Akbarian M; Gharibdoost F
Adv Exp Med Biol; 2003; 528():579-84. PubMed ID: 12918769
[No Abstract] [Full Text] [Related]
8. Gender influence on ocular manifestations and their outcome in Behcet's Disease. A long-term follow-up of up to 20 years.
Davatchi F; Shahram F; Shams H; Nadji A; Chams-Davatchi C; Akhlaghi M; Faezi ST; Ashofteh F; Sadeghi-Abdollahi B
Clin Rheumatol; 2011 Apr; 30(4):541-7. PubMed ID: 20857156
[TBL] [Abstract][Full Text] [Related]
9. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis.
Kötter I; Zierhut M; Eckstein A; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Peter HH; Kanz L; Stübiger N
Adv Exp Med Biol; 2003; 528():521-3. PubMed ID: 12918755
[No Abstract] [Full Text] [Related]
11. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
Niccoli L; Nannini C; Benucci M; Chindamo D; Cassarà E; Salvarani C; Cimino L; Gini G; Lenzetti I; Cantini F
Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
Zlatanović G; Jovanović S; Veselinović D; Zivković M
Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
[TBL] [Abstract][Full Text] [Related]
14. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Tabbara KF; Al-Hemidan AI
Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study.
Gül A; Tugal-Tutkun I; Dinarello CA; Reznikov L; Esen BA; Mirza A; Scannon P; Solinger A
Ann Rheum Dis; 2012 Apr; 71(4):563-6. PubMed ID: 22084392
[TBL] [Abstract][Full Text] [Related]
16. [Comparative evaluation of the effectiveness of corticosteroids and cytostatics in treating retinal angiitis in Behcet's disease].
Ermakova NA
Vestn Oftalmol; 2002; 118(5):32-5. PubMed ID: 12532744
[TBL] [Abstract][Full Text] [Related]
17. Ocular manifestations of late-onset behçet disease.
Citirik M; Berker N; Songur MS; Ozkan SS; Zilelioglu O
Ophthalmologica; 2011; 225(1):21-6. PubMed ID: 20693818
[TBL] [Abstract][Full Text] [Related]
18. [Eye and Behçet's disease].
Binisti P
Rev Prat; 1999 Nov; 49(18):1999-2003. PubMed ID: 10626485
[TBL] [Abstract][Full Text] [Related]
19. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.
Ferreira BFA; Rodriguez EEC; Prado LLD; Gonçalves CR; Hirata CE; Yamamoto JH
J Med Case Rep; 2017 Apr; 11(1):104. PubMed ID: 28410605
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of inflammatory cystoid macular edema.
Tranos PG; Tsaousis KT; Vakalis AN; Asteriades S; Pavesio CE
Retina; 2012 Sep; 32(8):1624-8. PubMed ID: 22481481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
